By Michael Erman (Reuters) -Bristol-Myers Squibb on Sunday said it will acquire cancer drugmaker Mirati Therapeutics for up to $5.8 billion, diversifying its oncology business and adding drugs it hope[...]
Read more
October 9, 2023
Arm’s shares get helping hand as IPO banks weigh in with ratings
By Aditya Soni and Roshan Abraham (Reuters) -Shares of Arm Holdings rose 3% on Monday after a wave of “buy” ratings from Wall Street analysts who said that the chip designer’s domina[...]
Read more
Russian rouble rebounds from over 18-month low vs dollar
By Alexander Marrow (Reuters) -The rouble rebounded after slumping to a more than 18-month low against the dollar on Monday in a volatile session, still hampered by reduced foreign currency supply but[...]
Read more
World Bank explores expanding loan guarantees for private financing
By Jorgelina do Rosario MARRAKECH (Reuters) – The World Bank on Monday said it is looking at ways to expand the guarantees it provides for commercial loans to boost the private financing availab[...]
Read more
Weight-loss drugs fuel boom for firms that fill syringes
By Maggie Fick LONDON (Reuters) – Contract drug manufacturers seeking to tap into the booming market for weight-loss drugs are investing billions of dollars to expand or build factories that fil[...]
Read more
Exclusive-ECB sees Italy’s spread jump as justified but may cool PEPP talk: sources
By Balazs Koranyi and Francesco Canepa FRANKFURT (Reuters) – European Central Bank policymakers consider a spike in Italy’s bond yields to be justified by the government’s projection[...]
Read more
Marketmind: Oil up but restrained on Mideast jolt
A look at the day ahead in U.S. and global markets from Mike Dolan The weekend’s Middle East shock adds another confusing twist to an already complicated global markets picture, but the initial[...]
Read more
US wealth, income concentration resume upward climb in post-pandemic era
By Howard Schneider WASHINGTON (Reuters) – The richest Americans are emerging from the coronavirus pandemic with their share of wealth and income on the rise again despite some thought that the[...]
Read more
Sam Bankman-Fried judge cracks jokes, loses patience with defense at FTX trial
By Luc Cohen NEW YORK (Reuters) – Sam Bankman-Fried’s fraud trial has featured dense testimony about computer code, cryptocurrency and corporate finance, but U.S. District Judge Lewis Kapl[...]
Read more